Knightscope, Inc. filed a Form 8-K on November 6, 2026, disclosing that it received a deficiency letter from Nasdaq on November 4, 2026, notifying the company that its Class A Common Stock has failed to meet the $1.00 per share minimum bid price requirement for continued listing on The Nasdaq Capital Market.

Key Highlights

  • Deficiency notice received: Knightscope's Class A Common Stock closed below $1.00 per share for the last 30 consecutive business days, triggering a deficiency under Nasdaq Listing Rule 5550(a)(2).
  • 180-day compliance window: The company has until May 3, 2027, to regain compliance with the Minimum Bid Price Requirement under Nasdaq Listing Rule 5810(c)(3)(A).
  • Compliance threshold: To satisfy the requirement before the deadline, the bid price must close at $1.00 or more per share for a minimum of ten consecutive business days.
  • Potential second period: If compliance is not achieved by May 3, 2027, the company may be eligible for an additional 180 calendar day compliance period, subject to meeting other Nasdaq listing standards.
  • Delisting risk: If the company does not regain compliance and is not eligible for an additional period, Nasdaq staff would notify the company that its Class A Common Stock will be subject to delisting, with an appeal option to a Nasdaq Hearings Panel.
  • No immediate listing impact: According to the filing, "the notification has no immediate effect on the Company's Nasdaq listing" and the stock continues to trade under the symbol "KSCP."

Knightscope Discloses Nasdaq Bid Price Deficiency and Compliance Timeline

According to the Form 8-K filed with the SEC, Knightscope, Inc. (NASDAQ:KSCP) received a deficiency letter dated November 4, 2026, from the Listing Qualifications Department of The Nasdaq Stock Market LLC. The letter notified the company that the closing bid price of its Class A Common Stock had fallen below the $1.00 per share minimum for the preceding 30 consecutive business days, placing it out of compliance with Nasdaq Listing Rule 5550(a)(2).

The filing states that the company has been provided a compliance period of 180 calendar days, running through May 3, 2027. During this window, if the closing bid price meets or exceeds $1.00 per share for at least ten consecutive business days, Nasdaq staff will issue written notification that compliance has been regained. The filing notes that the company "intends to actively monitor the closing bid price" and "may, if appropriate, consider implementing available options to regain compliance," which could include a reverse stock split if a second compliance period becomes necessary.

Should the company fail to meet the requirement by May 3, 2027, it may qualify for a second 180-day period, provided it satisfies continued listing requirements for market value of publicly held shares and all other initial listing standards, with the exception of the bid price rule. If neither condition is met, Nasdaq staff would issue a delisting notice. The company retains the right to appeal such a determination to a Nasdaq Hearings Panel, though the filing cautions that "there can be no assurance that such appeal would be successful." The filing was signed by William Santana Li, Chairman, Chief Executive Officer and President.

What Was Disclosed

Knightscope reported receiving a Nasdaq deficiency notice on November 4, 2026, for failing to maintain a $1.00 minimum bid price over 30 consecutive business days. The company has until May 3, 2027, to regain compliance, with trading continuing under symbol "KSCP" in the interim.